-
UPDATE: Applied Genetic Technologies (AGTC) on Watch on Chatter
-
Applied Genetic Technologies (AGTC) Prices 6.5M Share Common Offering at $5/Sh
-
AGTC Announces Pricing of $32,500,000 Public Offering of Common Stock
-
Applied Genetic Technologies (AGTC) Announces Proposed 6M Share Public Offering of Common Stock
-
AGTC Announces Proposed Public Offering of Common Stock
-
AGTC Announces Proposed Public Offering of Common Stock
-
Pre-Open Stock Movers 1/28: (DLPH) (XLRN) (ALKS) Higher (EROS) (BWA) (DDD) Lower (more...)
-
UPDATE: Roth Capital Starts Applied Genetic Technologies Corp. (AGTC) at Buy
-
After-Hours Movers 01/27: (XLRN) (SURF) (INO) Higher; (EROS) (FFIV) (RMBS) Lower (more...)
-
Pre-Open Movers 09/24: (AGTC) (EPZM) (XON) Higher; (NBEV) (TLRY) (CMCSA) Lower (more...)
-
Roth Capital Upgrades Applied Genetic Technologies Corp. (AGTC) to Buy
-
Roth Affirms Applied Genetic Tech (AGTC) at 'Neutral' Amid CNGA3 IND Filing; Application Expands Present Pipeline
-
Roth Capital Downgrades Applied Genetic Technologies Corp. (AGTC) to Neutral
-
Roth Reaffirms Applied Genetic (AGTC) at 'Buy' Following FY15 Results; Fundamental Thesis Remains Unchanged
-
Applied Genetic Tech (AGTC) Triggers Enrollment Milestone in XLRS Phase I/II; Roth Affirms at 'Buy'
-
Roth Capital Positive on Biogen (BIIB), AGTC (ATGC) Collaboration; Reaffirms AGTC at 'Buy'
-
Roth Capital Reiterates Buy For Applied Genetic Technologies (AGTC) Following Q3
-
Applied Genetic Tech (AGTC) Fundamentals Unchanged Amid NIH Publication on LCA w/ RPE65 Mutation
-
Streetinsider.com's Hot Lunchtime Reads 2/11: (AAPL) (OC) (IMMR) (FB)
-
2015 Expected to be 'Transformative' Year for Applied Genetic Technologies (AGTC) - Roth Capital
-
AGTC Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Applied Genetic Technologies (AGTC) Prices 2M Common Offering at $15/Share
-
AGTC Announces Pricing of Public Offering
-
Notable Analyst Rating Changes 04/21: (MS) (AWI) (HNI) Upgraded; (WLT) (MGI) (YUM) Downgraded
-
Roth Capital Starts Applied Genetic Tech (AGTC) at Buy; Catalysts in 2015 Add Appeal
-
AGTC Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Applied Genetic Technologies (AGTC) IPO Opens Higher
-
Applied Genetic Technologies (AGTC) IPO Prices at $12, Below Range
-
AGTC Announces Pricing of Initial Public Offering
-
Applied Genetic Technologies (AGTC) Files $70M IPO